🔗 Permalink

Inventor profile of:

Andrew Mark Griffin

City:

L'lle Bizard

Country:

Canada

Published Applications:

Last publication date:

2025-07-03

Top Assignees for applications by Andrew Mark Griffin

The entities that hold a legal rights for patent applications filed by inventor Griffin Andrew Mark:

Praxis Precision Medicines, Inc. 14 Boston, MA United States
Praxis Precision Medicines, Inc. 9 Cambridge, MA United States

Recent patent applications by Griffin Andrew Mark

Andrew Mark Griffin from L'lle Bizard, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-03

US20250214932A1

Chemistry; metallurgy

T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIRONONANE CORE AND METHODS OF USE THEREOF

#2 | 2025-07-03

US20250213558A1

Human necessities

T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF

#3 | 2024-02-08

US20240043415A1

Chemistry; metallurgy

KCNT1 INHIBITORS AND METHODS OF USE

#4 | 2024-01-25

US20240025852A1

Chemistry; metallurgy

T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF

#5 | 2023-11-02

US20230348466A1

Chemistry; metallurgy

FORMULATIONS OF ION CHANNEL MODULATORS AND METHODS OF PREPARATION AND USE OF ION CHANNEL MODULATORS

#6 | 2023-10-12

US20230322790A1

Chemistry; metallurgy

COMPOUNDS AND THEIR METHODS OF USE

#7 | 2023-09-14

US20230286984A1

Chemistry; metallurgy

ION CHANNEL MODULATORS

#8 | 2023-09-14

US20230285377A1

Human necessities

KCNT1 INHIBITORS AND METHODS OF USE

#9 | 2023-07-13

US20230219938A1

Chemistry; metallurgy

COMPOUNDS AND THEIR METHODS OF USE

#10 | 2023-07-13

US20230219921A1

Chemistry; metallurgy

KCNT1 INHIBITORS AND METHODS OF USE

#11 | 2023-06-01

US20230167102A1

Chemistry; metallurgy

KCNT1 INHIBITORS AND METHODS OF USE

#12 | 2022-09-08

US20220280476A1

Human necessities

KCNT1 INHIBITORS AND METHODS OF USE

#13 | 2022-08-18

US20220259193A1

Chemistry; metallurgy

KCNT1 INHIBITORS AND METHODS OF USE

#14 | 2022-07-14

US20220220118A1

Chemistry; metallurgy

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

#15 | 2022-07-14

US20220218681A1

Human necessities

Compounds and their methods of use

#16 | 2022-06-30

US20220204505A1

Chemistry; metallurgy

Ion channel modulators

#17 | 2022-05-05

US20220135553A1

Chemistry; metallurgy

KCNT1 inhibitors and methods of use

#18 | 2022-01-27

US20220024930A1

Chemistry; metallurgy

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

#19 | 2021-12-30

US20210403476A1

Chemistry; metallurgy

ION CHANNEL MODULATORS

#20 | 2021-11-18

US20210355118A1

Chemistry; metallurgy

Compounds and their methods of use

#21 | 2021-06-24

US20210188852A1

Chemistry; metallurgy

Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity

#22 | 2021-06-24

US20210188839A1

Chemistry; metallurgy

COMPOUNDS AND THEIR METHODS OF USE

#23 | 2021-06-10

US20210171530A1

Chemistry; metallurgy

Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

#24 | 2021-06-03

US20210163488A1

Chemistry; metallurgy

Ion channel modulators

#25 | 2021-03-25

US20210087197A1

Chemistry; metallurgy

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator

#26 | 2020-12-03

US20200377507A1

Chemistry; metallurgy

Substituted pyridines as ion channel modulators

#27 | 2020-12-03

US20200377506A1

Chemistry; metallurgy

Compounds and their methods of use

#28 | 2020-12-03

US20200377499A1

Chemistry; metallurgy

Ion channel modulators

#29 | 2020-08-06

US20200247793A1

Chemistry; metallurgy

Compounds and their methods of use

#30 | 2020-06-11

US20200179358A1

Human necessities

Compounds and their methods of use

#31 | 2019-12-26

US20190389868A1

Chemistry; metallurgy

Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel

InventorID:

2755295 ⎘